INMB vs XLO
Comparison between INmune Bio Inc (INMB, Company) and Xilio Therapeutics Inc (XLO, Company).
Both INMB and XLO are from the Healthcare sector.
5-Year PerformanceINMB has outperformed XLO, delivering a return of -39.4% compared to -50.0%
INMB vs XLO - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
INMB vs XLO - Historical Returns
Returns include dividend reinvestment.
INMB vs XLO - Annual Returns (2019 - 2026)
Returns include dividend reinvestment.
| Year | INMB | XLO |
|---|---|---|
| 2026 | +11.69% | -11.63% |
| 2025 | -68.36% | -40.17% |
| 2024 | -58.38% | +66.09% |
| 2023 | +67.81% | -79.55% |
| 2022 | -40.69% | -83.24% |
| 2021 | -42.24% | +0.00% |
| 2020 | +179.86% | N/A |
| 2019 | -27.41% | N/A |
INMB vs XLO Drawdown Comparison
The maximum drawdown for INMB was -95.98%, occurring on Mar 27, 2026. This drawdown has not yet recovered.
The maximum drawdown for XLO was -98.01%, occurring on Dec 20, 2023. This drawdown has not yet recovered.
The current INMB drawdown is -93.82%. The current XLO drawdown is -97.64%.
| Rank | INMB | XLO |
|---|---|---|
| #1 | -95.98% Sep 7, 2021 - Mar 27, 2026 | -98.01% Nov 16, 2021 - Dec 20, 2023 |
| #2 | -79.91% May 9, 2019 - Jul 14, 2020 | -15.07% Nov 2, 2021 - Nov 4, 2021 |
| #3 | -65.40% Jan 19, 2021 - Sep 7, 2021 | -7.66% Nov 4, 2021 - Nov 8, 2021 |
| #4 | -52.32% Jul 14, 2020 - Dec 31, 2020 | -6.89% Nov 8, 2021 - Nov 16, 2021 |
| #5 | -13.66% Feb 22, 2019 - Apr 8, 2019 | -2.19% Oct 26, 2021 - Oct 29, 2021 |
| #6 | -9.29% Feb 4, 2019 - Feb 22, 2019 | N/A |
| #7 | -8.60% Apr 10, 2019 - Apr 22, 2019 | N/A |
| #8 | -5.83% Jan 6, 2021 - Jan 11, 2021 | N/A |
| #9 | -4.14% Apr 22, 2019 - May 1, 2019 | N/A |
| #10 | -4.11% May 2, 2019 - May 9, 2019 | N/A |
| #11 | -0.40% Jan 14, 2021 - Jan 19, 2021 | N/A |
| #12 | -0.23% Jan 11, 2021 - Jan 13, 2021 | N/A |
Correlation
Correlation between INMB and XLO is 0.53 which considered as a moderate positive correlation - the stocks show some tendency to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks